Self-Management Data and Disease Progression in Chronic Kidney Disease
Recruiting · NCT07754097 · Observational (researchers observe without assigning treatment) · Lead sponsor: Chungnam National University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study evaluates disease progression and management characteristics in patients with chronic kidney disease (CKD) using an integrated mobile application and hospital information system (HIS) clinical data. The main goals of this study are: 1. To observe patient self-management recording performance and adherence (continuity of recording blood pressure, blood glucose, medication, and diet). 2. To explore associations between integrated self-management data and disease progression or acute exacerbations (e.g., acute kidney injury, hyperkalemia). 3. To gather foundational evidence for optimizing and improving future digital health applications for CKD management. Participants will be recruited from outpatient clinics at Chungnam National University Hospital and followed prospectively for 1 year with regular follow-up visits.
Who can take part
Inclusion criteria
- Adult patients aged 19 years or older and under 85 years.
- Patients visiting the hospital for chronic kidney disease (CKD) management.
- Patients diagnosed with CKD or identified as high-risk for CKD requiring continuous management (e.g., diabetes mellitus, hypertension, proteinuria, or decreased eGFR).
- Patients capable of recording self-management data (blood pressure, diet, medication) independently or with assistance through the provided mobile application.
- Patients whose clinical data can be collected from the Hospital Information System (HIS).
Exclusion criteria
- Patients who do not sign the informed consent form or lack the capacity to fully understand the study protocol and express voluntary consent.
- Patients currently undergoing maintenance dialysis (hemodialysis or peritoneal dialysis) for end-stage kidney disease (ESKD).
- Patients deemed unsuitable for participation in the study by the investigator.
Where it is running
1 location listed.
- Chungnam National University Hospital - Daejeon, DJ, South Korea